Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$$α$$ Inhibition for Cancer and Autoimmune Disease
Journal Article
·
· Cell Chemical Biology
Tumor necrosis factor alpha (TNF-α) has both positive and negative roles in human disease. In certain cancers, TNF-α is infused locally to promote tumor regression, but dose-limiting inflammatory effects limit broader utility. In autoimmune disease, anti-TNF-α antibodies control inflammation in most patients, but these benefits are offset during chronic treatment. TAK1 acts as a key mediator between survival and cell death in TNF-α-mediated signaling. In this paper, we describe Takinib, a potent and selective TAK1 inhibitor that induces apoptosis following TNF-α stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. We demonstrate that Takinib is an inhibitor of autophosphorylated and non-phosphorylated TAK1 that binds within the ATP-binding pocket and inhibits by slowing down the rate-limiting step of TAK1 activation. Overall, Takinib is an attractive starting point for the development of inhibitors that sensitize cells to TNF-α-induced cell death, with general implications for cancer and autoimmune disease treatment.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- Cancer Prevention and Research Institute of Texas (CPRIT); Fulbright Scholar Program; National Institutes of Health (NIH); ORNL Ralph E. Powe Junior Faculty Enhancement Award; USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23); Welch Foundation
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1464982
- Alternate ID(s):
- OSTI ID: 1510249
- Journal Information:
- Cell Chemical Biology, Journal Name: Cell Chemical Biology Journal Issue: 8 Vol. 24; ISSN 2451-9456
- Publisher:
- Cell Press - ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis
CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway
Journal Article
·
Fri Jul 19 04:00:00 UTC 2013
· Biochemical and Biophysical Research Communications
·
OSTI ID:22239671
CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway
Journal Article
·
Fri Jan 02 04:00:00 UTC 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22416886